Searchable abstracts of presentations at key conferences in endocrinology

ea0099p154 | Reproductive and Developmental Endocrinology | ECE2024

Aromatase inhibitors and abrupt increase obesity rates among in males during puberty

Jamburia Rezo , Bakhtadze Tekle , Janjgava Shota , Davitashvili Ana , Goletiani Natia , Zhgenti Medea , Giorgadze Elene

Even in the presence of normally circulating androgens, the imbalance between estrogen and androgen in males between the prepubertal and pubertal periods may have an impact on male reproductive function. While there are many variables that affect how each person reaches puberty at different times, boys who are becoming more obese have higher aromatase activity. This enzyme turns testosterone into estradiol permanently, which lowers testosterone levels and raises estrogen level...

ea0099ep772 | Reproductive and Developmental Endocrinology | ECE2024

Influence of aromatase inhibitors on metabolic parameters in obese male patient

Janjgava Shota , Jamburia Revazi , Davitashvili Ana , Bakhtadze Tekle , Zhgenti Medea , Goletiani Natia

Overview: Numerous epidemiological studies have demonstrated that low testosterone levels are linked to poor life quality and sexual quality, and that hypoestrogenic hypogonadism in obese male patients is connected with and predicts the development of metabolic syndrome and type 2 diabetes in the future. The purpose of the study was to demonstrate how aromatase inhibitors affected anthropometric traits, HOMA-IR, blood pressure, glycosylated hemoglobin level, and dyslipidemia i...